Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

Detect NTRK gene fusion status with FISH

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.

Use Zytovision FISH probes to detect gene fusion status in NTRK1/2/3 genes.

The ZytoLight Dual Color Break Apart Probes are to be used for the qualitative detection of translocations involving the human NTRK1, NTRK2, and NTRK3 genes in formalin-fixed, paraffin-embedded specimens by fluorescence in situ hybridization (FISH). The probes are intended to be used as an aid to the differential diagnosis of various cancers.

Item Number

Item Description

ZYZ216750

ZytoLight SPEC NTRK1 Dual Color Break Apart probe 0.05ml

ZYZ2167200

ZytoLight SPEC NTRK1 Dual Color Break Apart Probe 0.2 ml

ZYZ220550

ZytoLight SPEC NTRK2 Dual Color Break Apart probe 0.05ml

ZYZ2205200

ZytoLight SPEC NTRK2 Dual Color Break Apart Probe 0.2ml

ZYZ220650

ZytoLight SPEC NTRK3 Dual Color Break Apart probe 0.05ml

ZYZ2206200

ZytoLight SPEC NTRK3 Dual Color Break Apart Probe 0.2ml


ZytoLight® SPEC NTRK1 Dual Color Break Apart Probe

ZytoLight® SPEC NTRK1 Dual Color Break Apart Probe

Download Flyer >

ZytoLight® SPEC NTRK2 Dual Color Break Apart Probe

ZytoLight® SPEC NTRK2 Dual Color Break Apart Probe

Download Flyer >

ZytoLight® SPEC NTRK3 Dual Color Break Apart Probe

ZytoLight® SPEC NTRK3 Dual Color Break Apart Probe

Download Flyer >

 



Request a Quote

Request Quote

Recent Posts

ZytoVision – New ZytoLight Probes

NECTIN4  |  MALT1/IGH  |  TNFRSF14/1q25  |  PLAG1 (more…)

Read full article

ImmunoIVD – Spot-it™ Newborn Screening Assays

ImmunoIVD, Early Detection for Life-Saving interventions Brisbane, Australia – July 31, 2025 (more…)

Read full article

Asuragen – QuantideX ESR1 exoMutation Kit

ESR1 Mutations are the Leading Cause of Primary Treatment Resistance in HR+ mBC ESR1 gene codes for estrogen receptor alpha (ERα), and mutations in its ligand-binding domain…

Read full article